SurModics (SRDX)

26.41 +0.05  +0.19%  May 17, 8:00PM
Add to Watchlists Create an Alert

SurModics R&D Expense Quarterly:

3.362M for Dec. 31, 2012
View Full Chart

SurModics R&D Expense Quarterly Chart

    SurModics Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 3.362M
    Sept. 30, 2012 3.49M
    June 30, 2012 3.503M
    March 31, 2012 3.512M
    Dec. 31, 2011 3.638M
    Sept. 30, 2011 3.793M
    June 30, 2011 3.907M
    March 31, 2011 3.80M
    Dec. 31, 2010 2.505M
    Sept. 30, 2010 9.808M
    June 30, 2010 8.865M
    March 31, 2010 9.348M
    Dec. 31, 2009 4.719M
    Sept. 30, 2009 5.972M
    June 30, 2009 4.443M
    March 31, 2009 5.116M
    Dec. 31, 2008 5.648M
    Sept. 30, 2008 -9.104M
    June 30, 2008 10.51M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    SRDX R&D Expense Quarterly Benchmarks

    Companies
    Trinity Biotech 0.765M
    Abaxis 3.229M
    Meridian Bioscience 2.811M

    SRDX R&D Expense Quarterly Rankings

    Overall 88th percentile
    958 of 8008
    Sector 59th percentile
    280 of 685 in Healthcare
    Industry 73rd percentile
    17 of 65 in Diagnostics & Research

    SRDX R&D Expense Quarterly Range, Past 5 Years

    Minimum -9.104M Sep 2008
    Maximum 10.51M Jun 2008
    Average 4.570M